Drug Development Success: Positive clinical trial results for new drugs or expansions of existing drug uses drive the stock price upward.

Regulatory Decisions: FDA approvals or rejections of Jazz Pharmaceuticals' drugs significantly impact investor confidence and stock valuation.

Competition: Emergence of competing drugs or therapies for the same conditions can reduce Jazz's market share and decrease its stock price.

Financial Performance: Revenue, earnings, and profit margins reported in quarterly and annual financial statements directly influence investor perception and stock value.

Market Sentiment: Overall market conditions and investor attitudes towards the pharmaceutical sector affect Jazz's stock price.

Patent Protection: Expiration or challenges to patents on key drugs can lead to generic competition, impacting revenues and stock price.

Acquisitions & Partnerships: Strategic acquisitions, licensing agreements, or collaborations can positively impact the stock price by expanding Jazz's pipeline and market reach.

Economic Factors: Changes in macroeconomic conditions such as interest rates and inflation can affect investor behavior and stock valuations in general, including Jazz.